Exocrine Pancreatic Carcinogenesis and Autotaxin Expression

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Kadekar, Sandeep ^a   Silins, Ilona ^a   Korhonen, Anna ^b   Dreij, Kristian ^a   Al Anati, Lauy ^a   Högberg, Johan ^a   Stenius, Ulla ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTAXIN; GELATINASE B; LYSOPHOSPHATIDIC ACID; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CANCER RISK; CARCINOGENESIS; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ANALYSIS; INFLAMMATION; MALE; METASTASIS; MORTALITY; NONHUMAN; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RISK ASSESSMENT; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ACINAR CELLS; ADENOMA; ANIMALS; BIOLOGICAL ASSAY; CALCIUM; CARCINOMA; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DATA MINING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MODELS, GENETIC; PANCREATIC NEOPLASMS; PHOSPHORIC DIESTER HYDROLASES; RATS; TESTOSTERONE;

AGOUTI PACA; RATTUS;

EID: 84865580962     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043209     Document Type: Article

References (87)

1. Raimondi S, Maisonneuve P, Lowenfels AB, (2009) Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 6: 699-708.
2. Stelow EB, Shaco-Levy R, Bao F, Garcia J, Klimstra DS, (2010) Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma. Am J Surg Pathol 34: 510-518.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
4. Lau MK, Davila JA, Shaib YH, (2010) Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States. Pancreas 39: 458-462.
5. Levi F, Lucchini F, Negri E, La Vecchia C, (2003) Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas 27: 139-142.
6. Stewart SL, Cardinez CJ, Richardson LC, Norman L, Kaufmann R, et al. (2008) Surveillance for cancers associated with tobacco use-United States, 1999-2004. MMWR Surveill Summ 57: 1-33.
7. Zhou J, Enewold L, Stojadinovic A, Clifton GT, Potter JF, et al. (2010) Incidence rates of exocrine and endocrine pancreatic cancers in the United States. Cancer Causes Control 21: 853-861.
8. Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC, Michaud DS, Severinsen MT, et al. (2010) Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126: 2394-2403.
9. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, et al. (2010) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer.
10. Mueller NT, Odegaard A, Anderson K, Yuan JM, Gross M, et al. (2010) Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 19: 447-455.
11. Michaud DS, Vrieling A, Jiao L, Mendelsohn JB, Steplowski E, et al. (2010) Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control 21: 1213-1225.
12. Larsson SC, Wolk A, (2012) Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer.
13. Birk T, Mundt KA, Guldner K, Parsons W, Luippold RS, (2009) Mortality in the German porcelain industry 1985-2005: first results of an epidemiological cohort study. J Occup Environ Med 51: 373-385.
14. Koorstra JB, Hustinx SR, Offerhaus GJ, Maitra A, (2008) Pancreatic carcinogenesis. Pancreatology 8: 110-125.
15. Guerra C, Schuhmacher AJ, Canamero M, Grippo PJ, Verdaguer L, et al. (2007) Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11: 291-302.
16. Morris JPT, Wang SC, Hebrok M, (2010) KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 10: 683-695.
17. Longnecker DS, Millar PM, (1990) Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the pancreas. IARC Sci Publ pp. 241-257.
18. Rao MS, (1987) Animal models of exocrine pancreatic carcinogenesis. Cancer Metastasis Rev 6: 665-676.
19. Kadekar S, Peddada S, Silins I, French JE, Hogberg J, et al. (2012) Gender Differences in Chemical Carcinogenesis in National Toxicology Program 2-Year Bioassays. Toxicol Pathol.
20. Lhoste EF, Roebuck BD, Stern JE, Longnecker DS, (1987) Effect of orchiectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat. Pancreas 2: 38-43.
21. Korhonen A, O'Seaghdha D, Silins I, Sun L, Hogberg J, et al. (2012) Text mining for literature review and knowledge discovery in cancer risk assessment and research. PLoS One 7: e33427.
22. Korhonen A, Silins I, Sun L, Stenius U, (2009) The first step in the development of Text Mining technology for Cancer Risk Assessment: identifying and organizing scientific evidence in risk assessment literature. BMC Bioinformatics 10: 303.
23. Silins I, Korhonen A, Hogberg J, Stenius U, (2012) Data and literature gathering in chemical cancer risk assessment. Integr Environ Assess Manag 8: 412-417.
24. Sun L, Korhonen A, Silins I, Stenius U, (2009) User-Driven Development of Text Mining Resources for Cancer Risk Assessment. Proceedings of the Natural Language Processing in Biomedicine (BioNLP) 2009 Boulder, Colorado.
25. Hattis D, Chu M, Rahmioglu N, Goble R, Verma P, et al. (2009) A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis. Crit Rev Toxicol 39: 97-138.
26. Deer EL, Gonzalez-Hernandez J, Coursen JD, Shea JE, Ngatia J, et al. (2010) Phenotype and genotype of pancreatic cancer cell lines. Pancreas 39: 425-435.
27. Logsdon CD, Ji B, (2009) Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin Gastroenterol Hepatol 7: S40-43.
28. Liu PS, Chiung YM, Kao YY, Chen HT, (2006) 2,4-Toluene diisocyanate suppressed the calcium signaling of ligand gated ion channel receptors. Toxicology 219: 167-174.
29. Liu PS, Chiung YM, Kao YY, (2006) Effect of toluene diisocyanate on homeostasis of intracellular-free calcium in human neuroblastoma SH-SY5Y cells. Toxicol Appl Pharmacol 211: 106-114.
30. Kunzli BM, Berberat PO, Giese T, Csizmadia E, Kaczmarek E, et al. (2007) Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease. Am J Physiol Gastrointest Liver Physiol 292: G223-230.
31. Gorelick FS, Thrower E, (2009) The acinar cell and early pancreatitis responses. Clin Gastroenterol Hepatol 7: S10-14.
32. Shah AU, Sarwar A, Orabi AI, Gautam S, Grant WM, et al. (2009) Protease activation during in vivo pancreatitis is dependent on calcineurin activation. Am J Physiol Gastrointest Liver Physiol 297: G967-973.
33. Seifert A, Rau S, Kullertz G, Fischer B, Santos AN, (2009) TCDD induces cell migration via NFATc1/ATX-signaling in MCF-7 cells. Toxicol Lett 184: 26-32.
34. Komachi M, Tomura H, Malchinkhuu E, Tobo M, Mogi C, et al. (2009) LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. Carcinogenesis 30: 457-465.
35. Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, et al. (2004) Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J Biol Chem 279: 6595-6605.
36. Nakai Y, Ikeda H, Nakamura K, Kume Y, Fujishiro M, et al. (2011) Specific increase in serum autotaxin activity in patients with pancreatic cancer. Clin Biochem 44: 576-581.
37. Fuss B, Baba H, Phan T, Tuohy VK, Macklin WB, (1997) Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J Neurosci 17: 9095-9103.
38. Panupinthu N, Zhao L, Possmayer F, Ke HZ, Sims SM, et al. (2007) P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem 282: 3403-3412.
39. Panupinthu N, Rogers JT, Zhao L, Solano-Flores LP, Possmayer F, et al. (2008) P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. J Cell Biol 181: 859-871.
40. Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, et al. (2010) Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene.
41. Gu BJ, Wiley JS, (2006) Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 107: 4946-4953.
42. French DL, Ramos-DeSimone N, Rozinski K, Nuovo GJ, (1994) Matrix metalloproteinase-9 in tumor cell invasion. Ann N Y Acad Sci 732: 324-334.
43. Mroczko B, Lukaszewicz-Zajac M, Wereszczynska-Siemiatkowska U, Groblewska M, Gryko M, et al. (2009) Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor. Pancreas 38: 613-618.
44. Okudaira S, Yukiura H, Aoki J, (2010) Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Biochimie 92: 698-706.
45. Goulioumis AK, Varakis J, Goumas P, Papadaki H, (2011) Androgen receptor in laryngeal carcinoma: could there be an androgen-refractory tumor? ISRN Oncol 2011: 180518.
46. Graham TR, Yacoub R, Taliaferro-Smith L, Osunkoya AO, Odero-Marah VA, et al. (2010) Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. Breast Cancer Res Treat 123: 139-147.
47. Lhoste EF, Roebuck BD, Brinck-Johnsen T, Longnecker DS, (1987) Effect of castration and hormone replacement on azaserine-induced pancreatic carcinogenesis in male and female Fischer rats. Carcinogenesis 8: 699-703.
48. Nyska A, Jokinen MP, Brix AE, Sells DM, Wyde ME, et al. (2004) Exocrine pancreatic pathology in female Harlan Sprague-Dawley rats after chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds. Environ Health Perspect 112: 903-909.
49. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, et al. (2010) LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50: 157-186.
50. Li S, Wang B, Xu Y, Zhang J, (2011) Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. Mol Cancer 10: 18.
51. Albers HM, Dong A, van Meeteren LA, Egan DA, Sunkara M, et al. (2010) Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proc Natl Acad Sci U S A 107: 7257-7262.
52. Arita Y, Ito T, Oono T, Kawabe K, Hisano T, et al. (2008) Lysophosphatidic acid induced nuclear translocation of nuclear factor-kappaB in Panc-1 cells by mobilizing cytosolic free calcium. World J Gastroenterol 14: 4473-4479.
53. Yu S, Murph MM, Lu Y, Liu S, Hall HS, et al. (2008) Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst 100: 1630-1642.
54. Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, et al. (2009) Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15: 539-550.
55. Harper K, Arsenault D, Boulay-Jean S, Lauzier A, Lucien F, et al. (2010) Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation. Cancer Res 70: 4634-4643.
56. Dietrich C, Kaina B, (2010) The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis 31: 1319-1328.
57. Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, et al. (2000) Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 19: 241-247.
58. Choi S, Lee M, Shiu AL, Yo SJ, Hallden G, et al. (2007) GPR93 activation by protein hydrolysate induces CCK transcription and secretion in STC-1 cells. Am J Physiol Gastrointest Liver Physiol 292: G1366-1375.
59. Longnecker DS, Sumi C, (1990) Effects of sex steroid hormones on pancreatic cancer in the rat. Int J Pancreatol 7: 159-165.
60. Gonzalez-Arenas A, Avendano-Vazquez SE, Cabrera-Wrooman A, Tapia-Carrillo D, Larrea F, et al. (2008) Regulation of LPA receptor function by estrogens. Biochim Biophys Acta 1783: 253-262.
61. Hama K, Aoki J, Bandoh K, Inoue A, Endo T, et al. (2006) Lysophosphatidic receptor, LPA3, is positively and negatively regulated by progesterone and estrogen in the mouse uterus. Life Sci 79: 1736-1740.
62. Nakanaga K, Hama K, Aoki J, (2010) Autotaxin-an LPA producing enzyme with diverse functions. J Biochem 148: 13-24.
63. Maronpot RR, Flake G, Huff J, (2004) Relevance of animal carcinogenesis findings to human cancer predictions and prevention. Toxicol Pathol 32 Suppl 1: 40-48.
64. Sistare FD, Morton D, Alden C, Christensen J, Keller D, et al. (2011) An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines. Toxicol Pathol 39: 716-744.
65. Terhune PG, Heffess CS, Longnecker DS, (1994) Only wild-type c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas. Mol Carcinog 10: 110-114.
66. Terhune PG, Memoli VA, Longnecker DS, (1998) Evaluation of p53 mutation in pancreatic acinar cell carcinomas of humans and transgenic mice. Pancreas 16: 6-12.
67. Terhune PG, Phifer DM, Tosteson TD, Longnecker DS, (1998) K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev 7: 515-521.
68. Gidekel Friedlander SY, Chu GC, Snyder EL, Girnius N, Dibelius G, et al. (2009) Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 16: 379-389.
69. Puri S, Hebrok M, (2010) Cellular plasticity within the pancreas-lessons learned from development. Dev Cell 18: 342-356.
70. Grippo PJ, Nowlin PS, Demeure MJ, Longnecker DS, Sandgren EP, (2003) Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res 63: 2016-2019.
71. Habbe N, Shi G, Meguid RA, Fendrich V, Esni F, et al. (2008) Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A 105: 18913-18918.
72. Zhu L, Shi G, Schmidt CM, Hruban RH, Konieczny SF, (2007) Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol 171: 263-273.
73. De La OJ, Emerson LL, Goodman JL, Froebe SC, Illum BE, et al. (2008) Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A 105: 18907-18912.
74. Woutersen RA, van Garderen-Hoetmer A, Lamers CB, Scherer E, (1991) Early indicators of exocrine pancreas carcinogenesis produced by non-genotoxic agents. Mutat Res 248: 291-302.
75. Ross J, Barrowman JA, (1987) Effect of experimental pancreatic growth on the content of xenobiotic-metabolising enzymes in the pancreas. Gut 28 Suppl: 197-201.
76. Moolenaar WH, van Meeteren LA, Giepmans BN, (2004) The ins and outs of lysophosphatidic acid signaling. Bioessays 26: 870-881.
77. Tice DA, Szeto W, Soloviev I, Rubinfeld B, Fong SE, et al. (2002) Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling. J Biol Chem 277: 14329-14335.
78. Malbon CC, (2005) Beta-catenin, cancer, and G proteins: not just for frizzleds anymore. Sci STKE 2005: pe35.
79. Kortlever RM, Brummelkamp TR, van Meeteren LA, Moolenaar WH, Bernards R, (2008) Suppression of the p53-dependent replicative senescence response by lysophosphatidic acid signaling. Mol Cancer Res 6: 1452-1460.
80. Hurst-Kennedy J, Zhong M, Gupta V, Boyan BD, Schwartz Z, (2010) 24R,25-Dihydroxyvitamin D3, lysophosphatidic acid, and p53: a signaling axis in the inhibition of phosphate-induced chondrocyte apoptosis. J Steroid Biochem Mol Biol 122: 264-271.
81. Sun W, Yang J, (2010) Molecular basis of lysophosphatidic acid-induced NF-kappaB activation. Cell Signal 22: 1799-1803.
82. Wang Z, Banerjee S, Ahmad A, Li Y, Azmi AS, et al. (2011) Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-kappaB signaling pathways. PLoS One 6: e20537.
83. Heid I, Lubeseder-Martellato C, Sipos B, Mazur PK, Lesina M, et al. (2011) Early requirement of Rac1 in a mouse model of pancreatic cancer. Gastroenterology 141: 719-730, 719-730, 730, e711-717.
84. Sautin YY, Crawford JM, Svetlov SI, (2001) Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line. Am J Physiol Cell Physiol 281: C2010-2019.
85. Joslin EJ, Shankaran H, Opresko LK, Bollinger N, Lauffenburger DA, et al. (2010) Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context. Mol Biosyst 6: 1293-1306.
86. Li H, Huang C, Huang K, Wu W, Jiang T, et al. (2011) STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice. PLoS One 6: e25941.
87. Azare J, Doane A, Leslie K, Chang Q, Berishaj M, et al. (2011) Stat3 mediates expression of autotaxin in breast cancer. PLoS One 6: e27851.